CrossGen Wealth’s MetLife MET Stock Holding History

CrossGen Wealth’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$162K	Buy	1,913 +1	+0.1%	+$81	0.13%	70
2026 Q1	$135K	Buy	1,912 +3	+0.2%	+$225	0.12%	77
2025 Q4	$151K	Buy	+1,909	New	+$151K	0.13%	73

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CrossGen Wealth's MET Position: Q2 2026 in Review

CrossGen Wealth increased its MetLife (MET) stake by 0.05% in Q2 2026, buying an estimated $81 and bringing the position to 1,913 shares worth $162K. The position accounts for 0.13% of the portfolio, ranked #70.

CrossGen Wealth first reported a position in MET in Q4 2025 and has held it in 3 quarters since. 1,440 funds tracked by Wall St. Rank hold MET as of Q2 2026.

CrossGen Wealth held 1,913 shares of MetLife worth $162K as of Q2 2026.
CrossGen Wealth bought 1 MetLife share in Q2 2026, an estimated $81.
MetLife made up 0.13% of CrossGen Wealth's portfolio in Q2 2026, its #70 holding.
CrossGen Wealth first reported a position in MetLife in Q4 2025 and has held it in 3 quarters since.
1,440 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on CrossGen Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.